What obesity drugmakers see next in the market: More pills, easier access and drug combinations

Leave a Comment / By Market Social / January 24, 2026

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

Post navigation

Why a niche category of CRE lending is suddenly seeing record deals

Gov. Walz calls on Trump to halt ICE operations in Minnesota after another fatal shooting

Your email address will not be published. Required fields are marked *

Comment *

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Markets

Trading

About Us

Name * Only alphabets are allowed.

Password

Again Password

Referral (Optional)

Support Language

Whatsapp Number *

OTP